These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20387088)

  • 41. Glycyrrhizin inactivates toll-like receptor (TLR) signaling pathway to reduce lipopolysaccharide-induced acute lung injury by inhibiting TLR2.
    Kong D; Wang Z; Tian J; Liu T; Zhou H
    J Cell Physiol; 2019 Apr; 234(4):4597-4607. PubMed ID: 30203548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Umbelliferone Alleviates Lipopolysaccharide-Induced Inflammatory Responses in Acute Lung Injury by Down-Regulating TLR4/MyD88/NF-κB Signaling.
    Wang D; Wang X; Tong W; Cui Y; Li X; Sun H
    Inflammation; 2019 Apr; 42(2):440-448. PubMed ID: 30645708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TIPE2 ameliorates lipopolysaccharide-induced apoptosis and inflammation in acute lung injury.
    Wu X; Kong Q; Zhan L; Qiu Z; Huang Q; Song X
    Inflamm Res; 2019 Nov; 68(11):981-992. PubMed ID: 31486847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
    Jin J; Xu W; Wan B; Wang X; Zhou Z; Miao Y; Lv T; Song Y
    J Surg Res; 2019 Mar; 235():83-92. PubMed ID: 30691855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury.
    Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY
    Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324
    [No Abstract]   [Full Text] [Related]  

  • 47. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
    Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
    Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice.
    Shi R; Zhang J; Peng Z; Yuan S; Gao S; Chen L; Yuan Y
    Int J Mol Med; 2018 Apr; 41(4):2159-2168. PubMed ID: 29393375
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preventive and therapeutic effects of Danhong injection on lipopolysaccharide induced acute lung injury in mice.
    Wan LM; Tan L; Wang ZR; Liu SX; Wang YL; Liang SY; Zhong JB; Lin HS
    J Ethnopharmacol; 2013 Aug; 149(1):352-9. PubMed ID: 23850708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
    Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
    Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibroblast Growth Factor 21 dependent TLR4/MYD88/NF-κB signaling activation is involved in lipopolysaccharide-induced acute lung injury.
    Gao J; Liu Q; Li J; Hu C; Zhao W; Ma W; Yao M; Xing L
    Int Immunopharmacol; 2020 Mar; 80():106219. PubMed ID: 31991373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
    Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
    Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
    Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
    Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LYRM03, an ubenimex derivative, attenuates LPS-induced acute lung injury in mice by suppressing the TLR4 signaling pathway.
    He HQ; Wu YX; Nie YJ; Wang J; Ge M; Qian F
    Acta Pharmacol Sin; 2017 Mar; 38(3):342-350. PubMed ID: 28112185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 25-Hydroxycholesterol protects against acute lung injury via targeting MD-2.
    Ouyang W; Zhou H; Liu C; Wang S; Han Y; Xia J; Xu F
    J Cell Mol Med; 2018 Nov; 22(11):5494-5503. PubMed ID: 30091835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of mammalian target of rapamycin augments lipopolysaccharide-induced lung injury and apoptosis.
    Fielhaber JA; Carroll SF; Dydensborg AB; Shourian M; Triantafillopoulos A; Harel S; Hussain SN; Bouchard M; Qureshi ST; Kristof AS
    J Immunol; 2012 May; 188(9):4535-42. PubMed ID: 22450807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asiatic Acid Inhibits Lipopolysaccharide-Induced Acute Lung Injury in Mice.
    Li Z; Xiao X; Yang M
    Inflammation; 2016 Oct; 39(5):1642-8. PubMed ID: 27395046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ugonin M, a Helminthostachys zeylanica Constituent, Prevents LPS-Induced Acute Lung Injury through TLR4-Mediated MAPK and NF-κB Signaling Pathways.
    Wu KC; Huang SS; Kuo YH; Ho YL; Yang CS; Chang YS; Huang GJ
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28368327
    [No Abstract]   [Full Text] [Related]  

  • 59. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
    Luo Y; Che W; Zhao M
    Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model.
    Takashima K; Matsunaga N; Yoshimatsu M; Hazeki K; Kaisho T; Uekata M; Hazeki O; Akira S; Iizawa Y; Ii M
    Br J Pharmacol; 2009 Aug; 157(7):1250-62. PubMed ID: 19563534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.